These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 29188560
21. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number? Vass M, Kooistra AJ, Verhoeven S, Gloriam D, de Esch IJP, de Graaf C. Methods Mol Biol; 2018; 1705():73-113. PubMed ID: 29188559 [Abstract] [Full Text] [Related]
22. Current and Future Challenges in GPCR Drug Discovery. Topiol S. Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556 [Abstract] [Full Text] [Related]
23. Advances in Computational Techniques to Study GPCR-Ligand Recognition. Ciancetta A, Sabbadin D, Federico S, Spalluto G, Moro S. Trends Pharmacol Sci; 2015 Dec; 36(12):878-890. PubMed ID: 26538318 [Abstract] [Full Text] [Related]
24. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise. Yarnitzky T, Levit A, Niv MY. Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165 [Abstract] [Full Text] [Related]
25. New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova. Ciancetta A, Cuzzolin A, Deganutti G, Sturlese M, Salmaso V, Cristiani A, Sabbadin D, Moro S. Mol Inform; 2016 Sep; 35(8-9):440-8. PubMed ID: 27546048 [Abstract] [Full Text] [Related]
26. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines. Beuming T, Sherman W. J Chem Inf Model; 2012 Dec 21; 52(12):3263-77. PubMed ID: 23121495 [Abstract] [Full Text] [Related]
27. Structure modeling of all identified G protein-coupled receptors in the human genome. Zhang Y, Devries ME, Skolnick J. PLoS Comput Biol; 2006 Feb 21; 2(2):e13. PubMed ID: 16485037 [Abstract] [Full Text] [Related]
28. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor. Erol I, Aksoydan B, Kantarcioglu I, Durdagi S. Methods Mol Biol; 2018 Feb 21; 1824():431-448. PubMed ID: 30039423 [Abstract] [Full Text] [Related]
29. Modeling G protein-coupled receptors and their interactions with ligands. Costanzi S. Curr Opin Struct Biol; 2013 Apr 21; 23(2):185-90. PubMed ID: 23415855 [Abstract] [Full Text] [Related]
30. Identifying multiple active conformations in the G protein-coupled receptor activation landscape using computational methods. Dong SS, Goddard WA, Abrol R. Methods Cell Biol; 2017 Apr 21; 142():173-186. PubMed ID: 28964335 [Abstract] [Full Text] [Related]
31. Improving the Modeling of Extracellular Ligand Binding Pockets in RosettaGPCR for Conformational Selection. Liessmann F, Künze G, Meiler J. Int J Mol Sci; 2023 Apr 24; 24(9):. PubMed ID: 37175495 [Abstract] [Full Text] [Related]
32. Sequential application of ligand and structure based modeling approaches to index chemicals for their hH4R antagonism. Pappalardo M, Shachaf N, Basile L, Milardi D, Zeidan M, Raiyn J, Guccione S, Rayan A. PLoS One; 2014 Apr 24; 9(10):e109340. PubMed ID: 25330207 [Abstract] [Full Text] [Related]
33. GPCR crystal structures: Medicinal chemistry in the pocket. Shonberg J, Kling RC, Gmeiner P, Löber S. Bioorg Med Chem; 2015 Jul 15; 23(14):3880-906. PubMed ID: 25638496 [Abstract] [Full Text] [Related]
34. Reliability of AlphaFold2 Models in Virtual Drug Screening: A Focus on Selected Class A GPCRs. Alhumaid NK, Tawfik EA. Int J Mol Sci; 2024 Sep 21; 25(18):. PubMed ID: 39337622 [Abstract] [Full Text] [Related]
35. Homology Modeling of Class A G-Protein-Coupled Receptors in the Age of the Structure Boom. Tiss A, Ben Boubaker R, Henrion D, Guissouma H, Chabbert M. Methods Mol Biol; 2021 Sep 21; 2315():73-97. PubMed ID: 34302671 [Abstract] [Full Text] [Related]
36. GPCR-ModSim: A comprehensive web based solution for modeling G-protein coupled receptors. Esguerra M, Siretskiy A, Bello X, Sallander J, Gutiérrez-de-Terán H. Nucleic Acids Res; 2016 Jul 08; 44(W1):W455-62. PubMed ID: 27166369 [Abstract] [Full Text] [Related]
37. X-ray structure breakthroughs in the GPCR transmembrane region. Topiol S, Sabio M. Biochem Pharmacol; 2009 Jul 01; 78(1):11-20. PubMed ID: 19447219 [Abstract] [Full Text] [Related]
38. Guiding lead optimization with GPCR structure modeling and molecular dynamics. Heifetz A, James T, Morao I, Bodkin MJ, Biggin PC. Curr Opin Pharmacol; 2016 Oct 01; 30():14-21. PubMed ID: 27419904 [Abstract] [Full Text] [Related]
39. Molecular interaction fingerprint approaches for GPCR drug discovery. Vass M, Kooistra AJ, Ritschel T, Leurs R, de Esch IJ, de Graaf C. Curr Opin Pharmacol; 2016 Oct 01; 30():59-68. PubMed ID: 27479316 [Abstract] [Full Text] [Related]
40. Homology model-assisted elucidation of binding sites in GPCRs. Levit A, Barak D, Behrens M, Meyerhof W, Niv MY. Methods Mol Biol; 2012 Oct 01; 914():179-205. PubMed ID: 22976029 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]